Diagnostica Stago, the experts in Coagulation, is thrilled to announce a strategic partnership with Awanui, a renowned innovator in the delivery of health care in New Zealand.
Awanui Group is New Zealand’s leading provider of community and hospital laboratory and pathology services in Aotearoa. Their national network of laboratories and collection centres is responsible for collecting, analysing, and reporting over seven million patient samples and results each year. This represents around 75 per cent of all laboratory and pathology testing undertaken in New Zealand
The partnership will focus on improving the care experienced by patients across New Zealand, delivering quality results as quickly as possible , for coagulation testing across the country.
The partnership will see the first installation in New Zealand of Stago's latest sthemO range of instruments, alongside the innovative sthemE Manager data manager to offer the highest quality of coagulation testing across all communities served by Awanui in both the North and South Islands.
The new solution, based on Stago's proven VBDS* technology, will offer the highest levels of quality, standardisation, and efficiency, whilst the connectivity of sthemE Manager will provide specialised access to remote labs enhancing support and access across New Zealand.
Stago and Awanui believe in people and this commitment to improve the health of as many people as possible is in the DNA of both organisations. Together we will work to deliver Awanui ‘s goal of ensuring the timely flow of accurate and trusted medical information, available 24/7, and enabling the most significant impacts of their work for all New Zealanders.
Sandrine Richard, General Manager of Stago Australia and New Zealand, said: "As a long-standing actor for laboratories in New Zealand, we are delighted to have been chosen by Awanui as their new coagulation partner. Stago's aim is to be a reference for blood-based diagnosis to improve the health of as many people as possible, and this motivates all we do. It is perfectly aligned with the vision Awanui has for their pathology services. We look forward to working together to improve the care delivered to patients in all healthcare settings in New Zealand"
As we embark on this exciting journey, we invite our clients, partners, and stakeholders to stay tuned for more updates as we unfold new initiatives created from this partnership.
*Viscosity Based Detection System also called mechanical detection is insensitive to optical interferences that can be found in patients’ plasma